NCT01662518View on ClinicalTrials.gov

DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

June 30, 2016

Conditions
Macular EdemaRetinal Vein Occlusion
Interventions
DEVICE

Dexamethasone drug delivery system (DDS-25)

350 mg Dexamethasone posterior segment drug delivery system (DDS-25) injection into the vitreous cavity at baseline

Trial Locations (1)

15010-100

Centro de Pesquisa Rubens Siqueira, São José do Rio Preto

All Listed Sponsors
collaborator

University of Sao Paulo

OTHER

lead

Centro de Pesquisa Rubens Siqueira

OTHER

NCT01662518 - DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) | Biotech Hunter | Biotech Hunter